Moderna launches mRNA Platform Incubator Network
US-based biotech company Moderna has announced the launch of the mRNA Platform Incubator Network, linking Australian organisations with strength in translational and pharmaceutical science, early-phase clinical trials and regulatory science. According to the maker of the Spikevax COVID‑19 vaccine, the group aims to “advance mRNA medicine, foster scientific excellence in clinical translation in Australia and…
Details